| |
| |
|
| Insider
Information: |
Kumar Neil |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
4,897,443 |
|
|
Indirect Shares
|
31,586,701 |
|
|
| Direct
Value |
$136,834,557 |
|
|
|
Indirect Value
|
$3,059,486,897 |
|
|
| Total
Shares |
36,484,144 |
|
|
| Total
Value |
$3,196,321,454 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 481.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eidos Therapeutics, Inc. |
EIDX |
Chief Executive Office... |
2018-06-22 |
0 |
2019-07-03 |
24,575,501 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
|
2024-05-16 |
4,897,443 |
2024-05-16 |
2,008,408 |
Premium* |
|
|
Lianbio |
LIAN |
Director |
|
0 |
2021-10-29 |
5,002,792 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LIAN |
Lianbio |
Director |
– • – |
2021-10-29 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
5,002,792 |
|
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
Chief Executive Officer |
• • • |
2018-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
18,826,417 |
18,826,417 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• • – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,624,367 |
7,624,367 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
See Remarks |
• • – |
2019-07-01 |
4 |
OE |
$0.00 |
$0 |
I/I |
1,328,061 |
927,686 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2020-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,129 |
4,690,854 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2020-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,129 |
4,694,209 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,129 |
4,697,564 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2021-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,524 |
4,718,949 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2021-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,523 |
4,722,741 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2021-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,523 |
4,726,534 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2022-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,524 |
4,730,328 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2022-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,705 |
4,795,948 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,705 |
4,840,894 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2022-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,706 |
4,881,903 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2022-12-21 |
4 |
S |
$0.00 |
$0 |
I/I |
(200,000) |
995,686 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,706 |
4,881,903 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2023-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
102,249 |
4,915,446 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2023-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
102,250 |
4,915,447 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2023-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
102,249 |
4,915,446 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
102,249 |
4,915,446 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2024-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,667 |
4,928,191 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2022-05-16 |
4 |
D |
$6.74 |
$160,136 |
D/D |
(23,759) |
4,772,189 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2022-02-16 |
4 |
D |
$8.84 |
$27,271 |
D/D |
(3,085) |
4,727,243 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2022-11-17 |
4 |
S |
$9.40 |
$325,606 |
D/D |
(34,640) |
4,813,197 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2022-11-16 |
4 |
D |
$9.64 |
$328,396 |
D/D |
(34,066) |
4,847,837 |
0 |
- |
|
72 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
